HEADER TRANSFERASE 10-APR-15 4ZZN TITLE HUMAN ERK2 IN COMPLEX WITH AN INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 11-360; COMPND 5 SYNONYM: MAP KINASE 1, MAPK 1, ERT1, EXTRACELLULAR SIGNAL-REGULATED COMPND 6 KINASE 2, ERK-2, MAP KINASE ISOFORM P42, P42-MAPK, COMPND 7 MITOGEN-ACTIVATED PROTEIN KINASE 2, MAP KINASE 2, MAPK 2; COMPND 8 EC: 2.7.11.24; COMPND 9 ENGINEERED: YES; COMPND 10 OTHER_DETAILS: MODIFIED CYS 161 A SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR R.A.WARD,N.COLCLOUGH,M.CHALLINOR,J.E.DEBRECZENI,K.ECKERSLEY, AUTHOR 2 G.FAIRLEY,L.FERON,V.FLEMINGTON,M.A.GRAHAM,R.GREENWOOD,P.HOPCROFT, AUTHOR 3 T.D.HOWARD,M.JAMES,C.D.JONES,C.R.JONES,J.RENSHAW,K.ROBERTS,L.SNOW, AUTHOR 4 M.TONGE,K.YEUNG REVDAT 2 26-AUG-15 4ZZN 1 JRNL REVDAT 1 27-MAY-15 4ZZN 0 JRNL AUTH R.A.WARD,N.COLCLOUGH,M.CHALLINOR,J.DEBRECZENI,K.ECKERSLEY, JRNL AUTH 2 G.FAIRLEY,L.FERON,V.FLEMINGTON,M.A.GRAHAM,R.GREENWOOD, JRNL AUTH 3 P.HOPCROFT,T.D.HOWARD,M.JAMES,C.D.JONES,C.R.JONES,J.RENSHAW, JRNL AUTH 4 K.ROBERTS,L.SNOW,M.TONGE,K.YEUNG JRNL TITL STRUCTURE-GUIDED DESIGN OF HIGHLY SELECTIVE AND POTENT JRNL TITL 2 COVALENT INHIBITORS OF ERK1/2. JRNL REF J.MED.CHEM. V. 58 4790 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 25977981 JRNL DOI 10.1021/ACS.JMEDCHEM.5B00466 REMARK 2 REMARK 2 RESOLUTION. 1.33 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,WOMACK; REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.33 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.57 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.0 REMARK 3 COMPLETENESS FOR RANGE (%) : 70.84 REMARK 3 NUMBER OF REFLECTIONS : 61548 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.1747 REMARK 3 R VALUE (WORKING SET) : 0.1703 REMARK 3 FREE R VALUE : 0.2023 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 21.06 REMARK 3 FREE R VALUE TEST SET COUNT : 12960 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.33 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.36 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 5.66 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 359 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2156 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 290 REMARK 3 BIN R VALUE (WORKING SET) : 0.2084 REMARK 3 BIN FREE R VALUE : 0.2461 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 19.22 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 69 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2743 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 45 REMARK 3 SOLVENT ATOMS : 365 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.28 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.9899 REMARK 3 B22 (A**2) : -4.1049 REMARK 3 B33 (A**2) : 2.1150 REMARK 3 B12 (A**2) : 0.0000 REMARK 3 B13 (A**2) : 0.4857 REMARK 3 B23 (A**2) : 0.0000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.175 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.067 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.070 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.064 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.068 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.9573 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.9416 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2855 ; 2.00 ; HARMONIC REMARK 3 BOND ANGLES : 3874 ; 2.00 ; HARMONIC REMARK 3 TORSION ANGLES : 993 ; 2.00 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 70 ; 2.00 ; HARMONIC REMARK 3 GENERAL PLANES : 405 ; 5.00 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2855 ; 20.00 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 369 ; 5.00 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3685 ; 4.00 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 BOND ANGLES (DEGREES) : 1.06 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.54 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.50 REMARK 3 REMARK 3 TLS DETAILS. REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -3.9745 8.1885 47.1496 REMARK 3 T TENSOR REMARK 3 T11: -0.1636 T22: -0.1693 REMARK 3 T33: -0.1453 T12: 0.0101 REMARK 3 T13: 0.0043 T23: 0.0031 REMARK 3 L TENSOR REMARK 3 L11: 0.5417 L22: 0.1988 REMARK 3 L33: 0.9459 L12: 0.1275 REMARK 3 L13: 0.2177 L23: 0.0184 REMARK 3 S TENSOR REMARK 3 S11: -0.0088 S12: 0.0455 S13: 0.0415 REMARK 3 S21: -0.0182 S22: 0.0170 S23: 0.0034 REMARK 3 S31: -0.0372 S32: -0.0273 S33: -0.0081 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: IDEAL-DIST CONTACT TERM CONTACT SETUP. REMARK 3 ALL ATOMS HAVE CCP4 ATOM TYPE FROM LIBRARY REMARK 4 REMARK 4 4ZZN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-APR-15. REMARK 100 THE PDBE ID CODE IS EBI-63585. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JUL-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I02 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL (PILATUS) REMARK 200 DETECTOR MANUFACTURER : DECTRIS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 61571 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.33 REMARK 200 RESOLUTION RANGE LOW (A) : 28.57 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 70.9 REMARK 200 DATA REDUNDANCY : 3.0 REMARK 200 R MERGE (I) : 0.03 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.60 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.33 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.37 REMARK 200 COMPLETENESS FOR SHELL (%) : 5.8 REMARK 200 DATA REDUNDANCY IN SHELL : 1.3 REMARK 200 R MERGE FOR SHELL (I) : 0.42 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.90 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.97 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.85000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 328 REMARK 465 PHE A 329 REMARK 465 ASP A 330 REMARK 465 MET A 331 REMARK 465 GLU A 332 REMARK 465 LEU A 333 REMARK 465 PRO A 354 REMARK 465 GLY A 355 REMARK 465 TYR A 356 REMARK 465 ARG A 357 REMARK 465 SER A 358 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 97 CG CD CE NZ REMARK 470 LYS A 112 CE NZ REMARK 470 GLU A 184 CG CD OE1 OE2 REMARK 470 ARG A 223 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 313 CG CD OE1 NE2 REMARK 470 ASP A 334 CG OD1 OD2 REMARK 470 GLU A 347 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 MET A 291 SD MET A 291 CE -0.407 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 147 42.40 -150.03 REMARK 500 ASP A 165 95.37 59.43 REMARK 500 ASN A 199 20.08 -160.40 REMARK 500 TYR A 231 -72.07 -43.03 REMARK 500 LEU A 292 49.34 -96.47 REMARK 500 ASP A 316 91.45 -161.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A1354 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CQ8 A1355 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4ZZM RELATED DB: PDB REMARK 900 HUMAN ERK2 IN COMPLEX WITH AN IRREVERSIBLE INHIBITOR REMARK 900 RELATED ID: 4ZZO RELATED DB: PDB REMARK 900 HUMAN ERK2 IN COMPLEX WITH AN IRREVERSIBLE INHIBITOR DBREF 4ZZN A 9 358 UNP P28482 MK01_HUMAN 11 360 SEQADV 4ZZN LEU A 44 UNP P28482 VAL 46 CONFLICT SEQRES 1 A 350 PRO GLU MET VAL ARG GLY GLN VAL PHE ASP VAL GLY PRO SEQRES 2 A 350 ARG TYR THR ASN LEU SER TYR ILE GLY GLU GLY ALA TYR SEQRES 3 A 350 GLY MET VAL CYS SER ALA TYR ASP ASN LEU ASN LYS VAL SEQRES 4 A 350 ARG VAL ALA ILE LYS LYS ILE SER PRO PHE GLU HIS GLN SEQRES 5 A 350 THR TYR CYS GLN ARG THR LEU ARG GLU ILE LYS ILE LEU SEQRES 6 A 350 LEU ARG PHE ARG HIS GLU ASN ILE ILE GLY ILE ASN ASP SEQRES 7 A 350 ILE ILE ARG ALA PRO THR ILE GLU GLN MET LYS ASP VAL SEQRES 8 A 350 TYR ILE VAL GLN ASP LEU MET GLU THR ASP LEU TYR LYS SEQRES 9 A 350 LEU LEU LYS THR GLN HIS LEU SER ASN ASP HIS ILE CYS SEQRES 10 A 350 TYR PHE LEU TYR GLN ILE LEU ARG GLY LEU LYS TYR ILE SEQRES 11 A 350 HIS SER ALA ASN VAL LEU HIS ARG ASP LEU LYS PRO SER SEQRES 12 A 350 ASN LEU LEU LEU ASN THR THR CME ASP LEU LYS ILE CYS SEQRES 13 A 350 ASP PHE GLY LEU ALA ARG VAL ALA ASP PRO ASP HIS ASP SEQRES 14 A 350 HIS THR GLY PHE LEU THR GLU TYR VAL ALA THR ARG TRP SEQRES 15 A 350 TYR ARG ALA PRO GLU ILE MET LEU ASN SER LYS GLY TYR SEQRES 16 A 350 THR LYS SER ILE ASP ILE TRP SER VAL GLY CYS ILE LEU SEQRES 17 A 350 ALA GLU MET LEU SER ASN ARG PRO ILE PHE PRO GLY LYS SEQRES 18 A 350 HIS TYR LEU ASP GLN LEU ASN HIS ILE LEU GLY ILE LEU SEQRES 19 A 350 GLY SER PRO SER GLN GLU ASP LEU ASN CYS ILE ILE ASN SEQRES 20 A 350 LEU LYS ALA ARG ASN TYR LEU LEU SER LEU PRO HIS LYS SEQRES 21 A 350 ASN LYS VAL PRO TRP ASN ARG LEU PHE PRO ASN ALA ASP SEQRES 22 A 350 SER LYS ALA LEU ASP LEU LEU ASP LYS MET LEU THR PHE SEQRES 23 A 350 ASN PRO HIS LYS ARG ILE GLU VAL GLU GLN ALA LEU ALA SEQRES 24 A 350 HIS PRO TYR LEU GLU GLN TYR TYR ASP PRO SER ASP GLU SEQRES 25 A 350 PRO ILE ALA GLU ALA PRO PHE LYS PHE ASP MET GLU LEU SEQRES 26 A 350 ASP ASP LEU PRO LYS GLU LYS LEU LYS GLU LEU ILE PHE SEQRES 27 A 350 GLU GLU THR ALA ARG PHE GLN PRO GLY TYR ARG SER MODRES 4ZZN CME A 159 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE HET CME A 159 10 HET SO4 A1354 10 HET CQ8 A1355 25 HETNAM CQ8 2-[[5-CHLORANYL-2-(OXAN-4-YLAMINO)PYRIDIN-4- HETNAM 2 CQ8 YL]AMINO]-N-METHYL-BENZAMIDE HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM SO4 SULFATE ION FORMUL 2 CQ8 C18 H21 CL N4 O2 FORMUL 3 CME C5 H11 N O3 S2 FORMUL 4 SO4 O4 S 2- FORMUL 5 HOH *365(H2 O) HELIX 1 1 HIS A 59 PHE A 76 1 18 HELIX 2 2 LEU A 110 GLN A 117 1 8 HELIX 3 3 SER A 120 ALA A 141 1 22 HELIX 4 4 LYS A 149 SER A 151 5 3 HELIX 5 5 ASP A 173 ASP A 177 5 5 HELIX 6 6 THR A 188 ARG A 192 5 5 HELIX 7 7 ALA A 193 ASN A 199 1 7 HELIX 8 8 LYS A 205 ASN A 222 1 18 HELIX 9 9 LEU A 232 GLY A 243 1 12 HELIX 10 10 SER A 246 CYS A 252 1 7 HELIX 11 11 ASN A 255 SER A 264 1 10 HELIX 12 12 PRO A 272 PHE A 277 1 6 HELIX 13 13 ASP A 281 LEU A 292 1 12 HELIX 14 14 GLU A 301 ALA A 307 1 7 HELIX 15 15 HIS A 308 GLU A 312 5 5 HELIX 16 16 ASP A 316 GLU A 320 5 5 HELIX 17 17 PRO A 337 ALA A 350 1 14 HELIX 18 18 ARG A 351 GLN A 353 5 3 SHEET 1 AA 2 MET A 11 VAL A 12 0 SHEET 2 AA 2 GLN A 15 VAL A 16 -1 O GLN A 15 N VAL A 12 SHEET 1 AB 5 TYR A 23 GLY A 32 0 SHEET 2 AB 5 GLY A 35 ASP A 42 -1 O GLY A 35 N GLY A 32 SHEET 3 AB 5 VAL A 47 ILE A 54 -1 O VAL A 47 N ASP A 42 SHEET 4 AB 5 VAL A 99 ASP A 104 -1 O VAL A 99 N ILE A 54 SHEET 5 AB 5 ASP A 86 ILE A 88 -1 O ASP A 86 N VAL A 102 SHEET 1 AC 3 THR A 108 ASP A 109 0 SHEET 2 AC 3 LEU A 153 LEU A 155 -1 N LEU A 155 O THR A 108 SHEET 3 AC 3 LEU A 161 ILE A 163 -1 O LYS A 162 N LEU A 154 SHEET 1 AD 2 VAL A 143 LEU A 144 0 SHEET 2 AD 2 ARG A 170 VAL A 171 -1 O ARG A 170 N LEU A 144 LINK C THR A 158 N CME A 159 1555 1555 1.35 LINK C CME A 159 N ASP A 160 1555 1555 1.35 CISPEP 1 GLY A 20 PRO A 21 0 1.43 SITE 1 AC1 6 TYR A 185 ARG A 189 ARG A 192 TYR A 231 SITE 2 AC1 6 HOH A2219 HOH A2248 SITE 1 AC2 14 GLU A 31 VAL A 37 ALA A 50 GLN A 103 SITE 2 AC2 14 ASP A 104 MET A 106 GLU A 107 THR A 108 SITE 3 AC2 14 ASP A 109 ASN A 152 LEU A 154 CYS A 164 SITE 4 AC2 14 HOH A2137 HOH A2196 CRYST1 48.760 69.700 59.800 90.00 108.71 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020509 0.000000 0.006946 0.00000 SCALE2 0.000000 0.014347 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017655 0.00000